Adjuvant therapy use among Appalachian breast cancer survivors - Wikidata - awgldk - TriplyDB

Adjuvant therapy use among Appalachian breast cancer survivors

Adjuvant therapy use among Appalachian breast cancer survivors

http://www.wikidata.org/entity/Q30279083

about

Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.MED23 in endocrinotherapy for breast cancer Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.Oral antidiabetic drug use and associated health outcomes in cancer patients.Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study.Osteoporosis and musculoskeletal complications related to therapy of breast cancer

P2860

Q30275906-BB9CD538-CA79-4E79-BD2B-86FA98A52F47 Q33750787-E37796FB-0211-415A-BAE5-D2A55174A4FA Q33818100-30F44A36-C58A-4166-BD42-68D67315FFDE Q33857602-8DF0B8F2-ED75-46E7-A837-6364B890A2B9 Q40133673-77DA1C46-1B9F-4BC8-AD07-D9C7E6E60A54 Q44346721-38930196-F9AA-4710-8F3F-C542B9782765 Q45038805-4E96997B-B8F4-4102-9AF2-49132128F7BA Q47112006-CCD11AE3-7C36-4EEF-B2AF-F177002377E8 Q57108686-A9463A1B-88FD-48C1-8CA3-51C46BADE4C2

P2860

Adjuvant therapy use among Appalachian breast cancer survivors

http://www.wikidata.org/entity/Q30279083

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Adjuvant therapy use among Appalachian breast cancer survivors

@ast

Adjuvant therapy use among Appalachian breast cancer survivors

@en

type

label

Adjuvant therapy use among Appalachian breast cancer survivors

@ast

Adjuvant therapy use among Appalachian breast cancer survivors

@en

prefLabel

Adjuvant therapy use among Appalachian breast cancer survivors

@ast

Adjuvant therapy use among Appalachian breast cancer survivors

@en

P1433

Q30279083-2964E868-55C1-4130-8D91-61E49C07D878

P1476

Q30279083-CFBA9F0B-2EA0-4A5F-B767-C52324397B7F

P2093

Q30279083-0CBE0F4E-20EC-4F3F-A2FD-01D0B0B3EC60

Q30279083-340D9778-21B2-47BA-BFA4-B60F96EA55FF

Q30279083-48508635-060D-438E-9B64-FCF18B92A6D2

Q30279083-C1440D6F-756C-4A19-A7E5-247B68458568

Q30279083-C341E7B9-4FF0-47C4-A70E-C19402712B50

Q30279083-CC48ACE4-CE65-4AA9-B0F3-409DC9BD1B6D

P2860

Q30279083-04584EDF-1493-4F76-B982-C78369B98BE7

Q30279083-081582C1-E1DB-44BC-A87E-F980A23CAAE4

Q30279083-0CD9ABB0-0737-48B4-B795-550D130874E1

Q30279083-12B997AB-049A-4196-B444-E0616277D69D

Q30279083-17CFAAF8-16CE-4829-A357-5C5518F2918D

Q30279083-34AE642D-24E0-470B-8E40-15D8076E8C9F

Q30279083-35068819-A8F8-4D49-98CB-36C8E9EB1E1B

Q30279083-386F64DB-C144-4531-9941-D73D69B87DE8

Q30279083-438D51B8-8CD6-4624-96A0-D306ABD54950

Q30279083-4F926D34-D388-4ADE-B267-18520533BAF8

P304

Q30279083-9CB04F18-A920-4E87-93CB-FE4182CF2F47

P31

Q30279083-5F1D0A87-F572-4A3B-A13B-3361145F5561

P356

Q30279083-3037803E-7F96-45BC-B37E-1E42BEB73ED5

P407

Q30279083-30BBE6C7-55B9-4D2C-B502-434A47501D5A

P433

Q30279083-3ECC2E58-35F9-4AFE-807F-7F7F1520E05E

P478

Q30279083-E534045A-C753-454A-BBBE-79BBDFE3A812

P577

Q30279083-1E66CFFD-2E51-40E3-95B8-98630560EC3F

P698

Q30279083-F24A6C26-86E4-4B88-ABAF-2B4FE3BF21C8

P932

Q30279083-D8A06D80-B853-438A-A3A3-6BEDCD5B109E

P356

MD.0000000000001071

P1433

P1476

Adjuvant therapy use among Appalachian breast cancer survivors

@en

P2093

Fabian Camacho

http://www.w3.org/2001/XMLSchema#string

Joseph Donohoe

http://www.w3.org/2001/XMLSchema#string

Rajesh Balkrishnan

http://www.w3.org/2001/XMLSchema#string

Roger T Anderson

http://www.w3.org/2001/XMLSchema#string

Vincent D Marshall

http://www.w3.org/2001/XMLSchema#string

Xi Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer

Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.

P304

e1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001071

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26131828

http://www.w3.org/2001/XMLSchema#string

P932

4504563

http://www.w3.org/2001/XMLSchema#string